Curative Biotechnology Inc Cash Flow Quality Index
Curative Biotechnology Inc cash flow quality index. Curative Biotechnology Inc (CUBT) has a Cash Flow Quality Index of -0.04x as of March 2020. Operating cash flow of $-14.53K is below net income of $363.64K, suggesting accrual-heavy earnings not yet converted to cash. See Curative Biotechnology Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Curative Biotechnology Inc (2015–2019)
Cash flow quality index of Curative Biotechnology Inc from 2015 to 2019. Historical Cash Flow Quality Index for Curative Biotechnology Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Curative Biotechnology Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Curative Biotechnology Inc Cash Flow Quality Index by Year (2015–2019)
Curative Biotechnology Inc cash flow quality index by year from 2015 to 2019. Year-by-year earnings quality comparison for Curative Biotechnology Inc. For the full cash flow conversion analysis, see Curative Biotechnology Inc cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $-150.00 | $331.95K | ▼ -104.4% |
| 2015 | 0.01x | $1.96K | $190.84K | — |